Vimarsana
Biggest News Aggregation in the World

Page 14 - Nasdaq Regn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Regn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Regn Today - Breaking & Trending Today

Regeneron Pharmaceuticals (NASDAQ:REGN) Reaches New 52-Week High at $958.48 - Vimarsana News

Regeneron Pharmaceuticals (NASDAQ:REGN) Reaches New 52-Week High at $958.48

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) shares hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $958.48 and last traded at $955.78, with a volume of 19778 shares changing hands. The stock had previously closed at $955.80. Analyst Upgrades and Downgrades Several brokerages have issued […]

Source: wkrb13.com
Schechter Investment Advisors LLC Cuts Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Vimarsana News

Schechter Investment Advisors LLC Cuts Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Schechter Investment Advisors LLC cut its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 2.5% in the 3rd quarter, Holdings Channel reports. The fund owned 982 shares of the biopharmaceutical company’s stock after selling 25 shares during the quarter. Schechter Investment Advisors LLC’s holdings in Regeneron Pharmaceuticals were worth $808,000 at the end […]

Source: wkrb13.com
Childress Capital Advisors LLC Buys New Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Vimarsana News

Childress Capital Advisors LLC Buys New Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Childress Capital Advisors LLC purchased a new position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 362 shares of the biopharmaceutical company’s stock, valued at approximately $298,000. Several other institutional investors and hedge funds […]

Childress Capital Advisors LLC Takes $298,000 Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Vimarsana News

Childress Capital Advisors LLC Takes $298,000 Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Childress Capital Advisors LLC acquired a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 362 shares of the biopharmaceutical company’s stock, valued at approximately $298,000. Several other institutional investors have also […]

Flputnam Investment Management Co. Raises Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Vimarsana News

Flputnam Investment Management Co. Raises Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Flputnam Investment Management Co. grew its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 18,753 shares of the biopharmaceutical company’s stock after acquiring an additional 303 shares during the […]